Ionic Liquid-Based Skin Patches Deliver Peptide Vaccines More Effectively Than Injections

A biocompatible ionic liquid formulation increased transdermal peptide delivery 28-fold and produced superior anti-tumor vaccination effects compared to injection.

Tahara, Yoshiro et al.·Molecular pharmaceutics·2020·Preliminary Evidenceanimal study
RPEP-05155Animal studyPreliminary Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal study
Evidence
Preliminary Evidence
Sample
N=small
Participants
Mice (transdermal vaccination and tumor suppression model)

What This Study Found

Choline-oleate ionic liquid increased transdermal antigen peptide delivery 28-fold and produced superior anti-tumor vaccination effects compared to traditional injection.

Key Numbers

28-fold ↑ transdermal flux; 7 fatty acids screened; C18:1 selected; tumor suppression > injection; no skin irritation

How They Did This

In vitro skin permeation studies, in vivo tumor growth suppression in vaccinated mice, 3D skin irritation model, and histological assessment.

Why This Research Matters

Needle-free vaccination through the skin could improve compliance and cold chain logistics. This biocompatible formulation achieves better immune responses than injection.

The Bigger Picture

This technology could enable needle-free peptide vaccines and transdermal delivery of other peptide therapeutics, making treatments more accessible and patient-friendly.

What This Study Doesn't Tell Us

Mouse study with a single antigen peptide. Human skin permeation may differ. Long-term stability of the formulation not assessed.

Questions This Raises

  • ?Can this formulation deliver other therapeutic peptides through human skin?
  • ?Would repeated application cause cumulative skin sensitization?
  • ?How does the immune response compare to standard adjuvanted injection?

Trust & Context

Key Stat:
28-fold Increase in transdermal peptide delivery using ionic liquid formulation compared to aqueous vehicle
Evidence Grade:
Animal study with strong quantitative delivery data and functional vaccination outcome. Promising but requires human skin and clinical testing.
Study Age:
Published in 2020. Ionic liquid drug delivery is an active research area.
Original Title:
Biocompatible Ionic Liquid Enhances Transdermal Antigen Peptide Delivery and Preventive Vaccination Effect.
Published In:
Molecular pharmaceutics, 17(10), 3845-3856 (2020)
Database ID:
RPEP-05155

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How does this deliver peptides through the skin?

An ionic liquid made from choline and oleic acid dissolves the peptide in an oil-based formulation that penetrates the skin barrier. This combination increases peptide absorption through the skin by 28 times compared to water-based delivery.

Why is skin-based vaccination better than injection?

The skin is rich in immune cells, so delivering vaccine peptides through the skin can produce stronger immune responses. This study showed transdermal vaccination suppressed tumor growth better than injection, without needles or skin irritation.

Read More on RethinkPeptides

Cite This Study

RPEP-05155·https://rethinkpeptides.com/research/RPEP-05155

APA

Tahara, Yoshiro; Morita, Kaho; Wakabayashi, Rie; Kamiya, Noriho; Goto, Masahiro. (2020). Biocompatible Ionic Liquid Enhances Transdermal Antigen Peptide Delivery and Preventive Vaccination Effect.. Molecular pharmaceutics, 17(10), 3845-3856. https://doi.org/10.1021/acs.molpharmaceut.0c00598

MLA

Tahara, Yoshiro, et al. "Biocompatible Ionic Liquid Enhances Transdermal Antigen Peptide Delivery and Preventive Vaccination Effect.." Molecular pharmaceutics, 2020. https://doi.org/10.1021/acs.molpharmaceut.0c00598

RethinkPeptides

RethinkPeptides Research Database. "Biocompatible Ionic Liquid Enhances Transdermal Antigen Pept..." RPEP-05155. Retrieved from https://rethinkpeptides.com/research/tahara-2020-biocompatible-ionic-liquid-enhances

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.